NCT06255860View on ClinicalTrials.gov

COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO)

CompletedOBSERVATIONAL

Enrollment

204

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions

Sars-CoV-2 InfectionMIS-C

Trial Locations (1)

94000

ACTIV, Créteil

All Listed Sponsors

lead

Association Clinique Thérapeutique Infantile du val de Marne

OTHER